ELAQUIS Trademark

Trademark Overview

On Wednesday, April 22, 2009, a trademark application was filed for ELAQUIS with the United States Patent and Trademark Office. The USPTO has given the ELAQUIS trademark a serial number of 77719476. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 30, 2009. This trademark is owned by Pfizer Inc.. The ELAQUIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
elaquis

General Information

Serial Number77719476
Word MarkELAQUIS
Filing DateWednesday, April 22, 2009
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 30, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 27, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, December 30, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 30, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, June 4, 2009UNDELIVERABLE MAIL - COURTESY COPY MAILED
Wednesday, June 3, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 3, 2009NON-FINAL ACTION E-MAILED
Wednesday, June 3, 2009NON-FINAL ACTION WRITTEN
Wednesday, June 3, 2009ASSIGNED TO EXAMINER
Monday, April 27, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 25, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

elaquis preparations pharmaceutical treatment human vaccines dysfunction allergies erectile disorders viral